title: Vasopressin receptors in human adrenal medulla and pheochromocytoma.
abstract: The nature of vasopressin (VP) receptors present in normal and tumoral human adrenal was investigated using various experimental approaches. Specific VP-binding sites were detected by autoradiography using [3H]arginine VP as a radioligand in adrenal cortex and medulla. The V1a receptor subtype was expressed in the two parts of the gland, as shown by pharmacological studies and RT-PCR experiments. By contrast, the V1b receptor subtype was only expressed in medullary chromaffin cells. This was confirmed by the characterization of V1b transcripts detected in adrenal medulla tissues. In pheochromocytoma, we also detected functional V1b receptors. These receptors triggered intracellular calcium mobilization from intracellular pools and were involved in catecholamine secretion. Binding experiments performed on pheochromocytoma plasma membrane preparations also revealed V1a vasopressin-binding sites, whose roles and cellular localization have not yet been determined. RT-PCR experiments confirmed these data; 100% and 80% of the five tumors tested exhibited V1a and V1b transcripts, respectively. Perifusion experiments also demonstrated that some pheochromocytomas may secrete large amounts of VP. Our findings imply that VP locally secreted by human adrenal medulla may regulate adrenal function by acting on V1a or V1b receptors. More interestingly, we demonstrate that one pheochromocytoma oversecretes VP. In this particular case, this may contribute to the increase in blood pressure observed.
authors.affiliation: INSERM U-469, CCIPE, Montpellier, France.
authors.forename: E
authors.initials: E
authors.lastname: Grazzini
authors.forename: C
authors.initials: C
authors.lastname: Breton
authors.forename: S
authors.initials: S
authors.lastname: Derick
authors.forename: M
authors.initials: M
authors.lastname: Andres
authors.forename: D
authors.initials: D
authors.lastname: Raufaste
authors.forename: F
authors.initials: F
authors.lastname: Rickwaert
authors.forename: G
authors.initials: G
authors.lastname: Boccara
authors.forename: P
authors.initials: P
authors.lastname: Colson
authors.forename: N C
authors.initials: NC
authors.lastname: Guérineau
authors.forename: C
authors.initials: C
authors.lastname: Serradeil-le Gal
authors.forename: G
authors.initials: G
authors.lastname: Guillon
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D000313:Adrenal Medulla / Q000166:cytology / Q000502:physiology*; D000328:Adult; D001127:Arginine Vasopressin / Q000378:metabolism; D001345:Autoradiography; D002118:Calcium / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured; D005089:Exocytosis / Q000502:physiology; D006727:Hormone Antagonists / Q000378:metabolism; D006801:Humans; D007211:Indoles / Q000378:metabolism; D008875:Middle Aged; D010673:Pheochromocytoma / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D011759:Pyrrolidines / Q000378:metabolism; D017483:Receptors, Vasopressin / Q000235:genetics / Q000502:physiology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured
chemical_list: D006727:Hormone Antagonists; D007211:Indoles; D011759:Pyrrolidines; D017483:Receptors, Vasopressin; D001127:Arginine Vasopressin; C082134:relcovaptan; D002118:Calcium